Acute Ischemic Stroke With Central Retinal Artery Occlusion as a Rare Presentation of COVID-19 Disease
S K Jakaria Been Sayeed1, Subir Chandra Das2, Reaz Mahmud3
1Medicine, National Institute of Neurosciences and Hospital, Dhaka, BGD.
Insights
This case report details a patient experiencing ischemic stroke and central retinal artery occlusion after COVID-19. It highlights the need for further research into COVID-19
Area of Science:
- Neurology
- Ophthalmology
- Infectious Diseases
Background:
- Coronavirus disease 2019 (COVID-19) is associated with inflammatory and pro-coagulant changes.
- Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) binds to angiotensin-converting enzyme 2 (ACE2) receptors, initiating inflammatory pathways.
- The impact of COVID-19 on cerebral and retinal vascular systems remains incompletely understood.
Observation:
- A patient developed a border-zone ischemic stroke concurrently with central retinal artery occlusion (RAO).
- This dual vascular event occurred following a diagnosis of COVID-19.
- The combined presentation of central RAO and ischemic stroke following COVID-19 has not been previously documented.
Findings:
- COVID-19-induced inflammation may contribute to thrombotic events in both arterial and venous circulation.
- While ACE2 receptor binding is key to SARS-CoV-2 inflammation, central RAO pathogenesis is multifactorial.
- The co-occurrence of ischemic stroke and central RAO suggests a potential link to COVID-19's vascular effects.
Implications:
- This case underscores the complex and potentially severe neurological and ophthalmological complications of COVID-19.
- Current treatment guidelines for this specific combined presentation are lacking.
- Further research is warranted to understand the pathogenesis and establish treatment protocols for COVID-19-associated cerebroretinal vascular events.
Abstract:
In this report, we present a case where the patient developed a border-zone ischemic stroke with central retinal artery occlusion (RAO) following coronavirus disease 2019 (COVID-19) disease. The COVID-19 disease has been described to induce inflammatory changes that predispose to thrombotic disease in both venous and arterial circulation. Angiotensin-converting enzyme 2 (ACE2) receptor expression in the blood vessel with which severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) binds is the cornerstone of inflammation although the pathogenesis of central RAO is multifactorial. The effects of COVID-19 inflammatory and pro-coagulant state on cerebral and retinal vascular systems are still inadequately understood. Combined presentation of central RAO with ischemic stroke has not been documented in the literature yet. As of now, no guidelines exist regarding treatment modalities to be employed in such instances. Hence, further research is warranted regarding the treatment of this condition with respect to the association with COVID-19.
Related Concept Videos
Stroke: Introduction and Types
Ischemic Stroke l: Introduction
Ischemic Stroke ll: Pathophysiology
Hemorrhagic Stroke l: Introduction
Hemorrhagic Stroke ll: Pathophysiology
Transient Ischemic Attack l: Introduction


